CURATIVE BIOTECHNOLOGY, INC.

Press Releases Curative Biotechnology, Inc. OTC Markets

Equities

CUBT

US23128N1081

End-of-day quote OTC Markets Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
0.0164 ^USD	+12.33%		-6.29%	-23.00%

2021

Curative Biotechnology, Inc. Appoints Marc Drimer to Board of Directors as Independent Director and Chairman of Audit Committee

CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Curative Biotechnology, Inc. Names Cary Sucoff to Board of Directors	12/22/12	PR
Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration	03/22/03	PR
Curative Biotechnology Announces Cooperative Research and Development Agreement(CRADA) with the National Eye Institute (NEI) for Clinical Evaluation of its Proprietary Ocular Metformin Formulation in Age-Related Macular Degeneration	21/22/21	PR
Curative Biotechnology : Announces IMT504 License For Development Of Proprietary Next-Gen COVID-19 Vaccine	07/21/07	PR
Curative Biotechnology : Appoints Marc Drimer, CPA to Board of Directors as Independent Director and Chairman of Audit Committee	15/21/15	AQ
Choroideremia Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight \| 4D Molecular Therapeutics, Roche, Biogen and Many Others	08/21/08	AQ
Curative Biotechnology, Inc. Files 2021 First Quarter Financials and Issues Letter to Shareholders	25/21/25	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer